ArticlePloS one2015

Correction: Effective Therapeutic Approach for Head and Neck Cancer by an Engineered Minibody Targeting the EGFR Receptor.

PLOS ONE StaffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.